Chat with us, powered by LiveChat
Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Research Insight   >   Nerve repair and regeneration Market by product (nerve repair by neurostimulation, nerve repair by biomaterials) –Asian Forecasts to 2019
Connect With Us
US/CAN : +1-888-502-0539

Nerve repair and regeneration Market by product (nerve repair by neurostimulation, nerve repair by biomaterials) –Asian Forecasts to 2019


The nerve repair and regeneration market in Asia is expected to grow significantly (CAGR 11.7%) due to a lot of opportunities in hand to penetrate the market, growing demand, and the growing treatment & procedures for various kinds of surgeries that deal with intensely damaged nerves. This has led to the growth of the nerve repair neurostimulation market.

Download PDF Brochure @ http://www.micromarketmonitor.com/contact/8309646246-download_pdf_brochure.html

Technological advancements has been a key driver in this market, with a number of leading companies focusing on innovation in order to make the surgery results more accurate than ever. For example, in November 2014, Stryker Corporation’s spine division launched its ALIF anchor-based technology, which is used to elicit vertebral bodies; the launch had taken place during the North American Spine Society’s Annual meet in San Francisco, which is expected to help the company strengthen its product portfolio.

Speak to Analyst @ http://www.micromarketmonitor.com/contact/8309646246-speak_to_analyst.html

Increasing regulatory approvals from regulatory authorities such as FDA and CE contribute to the growth of the nerve repair and regeneration market. These approvals permit companies to initiate installations as well as selling and marketing products in various regions.
France is the fastest growing country for the nerve repair and regeneration market. This growth is due to various factors such as increasing disease diagnosis for Parkinson’s and epilepsy, M&A amongst market players, ageing population, increasing number of surgeries, FDA Approvals, increasing expenditures on health, etc.